Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care

[PR Newswire] – BOSTON and INDIANAPOLIS, April 9, 2014 /PRNewswire/ — T1D Exchange and Eli Lilly and Company (LLY) announced today they have entered into a research collaboration that will enable both organizations . . . → Read More: Stock Update: Eli Lilly & Company (NYSE:LLY) – Lilly and T1D Exchange Announce Research Collaboration to Inform Development of New Initiatives to Advance Diabetes Care Similar Articles: Eli Lilly & Company (NYSE:LLY) – NY Family Wins $9 Billion in Trial Over Cancer Linked to Diabetes Drug Actos Market Update: Eli Lilly & Company (NYSE:LLY) – Eli Lilly and Company Expands Authorized Generic Agreements with Prasco® Stock Update: Eli Lilly & Company (NYSE:LLY) – EU agency backs new drugs from J&J, Lilly, Takeda